MEC Practice Academy 11.19
|Articles|July 9, 2010

Oral, IV steroids offer similar efficacy for COPD

Patients with chronic obstructive pulmonary disease exacerbations treated with low-dose oral corticosteroids have outcomes similar to those treated with more costly and invasive high-dose intravenous corticosteroid therapy, according to new research.

JAMA. 2010;303:2359-2367. [June 16, 2010]

Patients with chronic obstructive pulmonary disease (COPD) exacerbations treated with low-dose oral corticosteroids have outcomes similar to those treated with more costly and invasive high-dose intravenous corticosteroid therapy, according to researchers from Baystate Medical Center in Springfield, Massachusetts. They assembled data on 79,985 patients hospitalized for acute COPD exacerbations at 414 hospitals during 2006 and 2007. In the intravenous group, 1.4 percent died and 10.9 percent experienced treatment failure, while in the oral group, 1.0 percent died and 10.3 percent experienced treatment failure. Furthermore, patients in the oral group had shorter hospital stays and lower costs.


Related to this article

Qasim Faizan: ©WeBill Health
Starting Jan. 1, Medicare will pay 20% less for the lower-valued service when an office visit billed with modifier 25 falls on the same day as a zero-day global procedure. One claims report priced at local 2027 rates shows independent practices their exposure, and three documentation habits protect the visits that still qualify for full payment.